Researchers call for transparent ethic committees

September 29, 2016 by Dominic Younger, University of Dundee
Researchers call for transparent ethic committees
Credit: University of Dundee

Poor regulation of research can cause direct harm to patients, suggests a new research study led by the University of Dundee.

The international study led by Dr Jonathan Mendel from the University has called for greater transparency in ethics committee processes.

The report, which saw input from researchers across the UK and Australia, has been published in the British Medical Journal (BMJ).

Investigating the process of ethical approval and the information given to patients with rheumatoid arthritis in , the study suggests that by making documentation freely available, it will allow ethical decisions to be independently reviewed, publicly discussed, and learnt from.

It further suggests that systematic review of evidence could allow for more effective scrutiny by Research Ethics Committees prior to publication.

Dr Mendel, a Lecturer in Human Geography whose research covers social aspects of trials amongst other areas, said, "We have shown that ethics processes around trials can lead to problematic decisions, which risk having significant impact on trial participants.

"Ethics processes are important to society, and should be open to public scrutiny. This is vital, both to minimise avoidable participant harms and to maintain public trust."

Dr Ben Goldacre from the University of Oxford, said, "Transparency for clinical trials is now firmly on the agenda with campaigns such as AllTrials. But transparency requires more than trial results. We can only be confident that patients' interests are being protected if all consent forms and ethics deliberations are publicly available."

Explore further: Big pharma inconsistent with disclosure of information on clinical trials, new study finds

More information: Jonathan Mendel et al. Problems with ethical approval and how to fix them: lessons from three trials in rheumatoid arthritis, BMJ (2016). DOI: 10.1136/bmj.i4626

Related Stories

Big pharma inconsistent with disclosure of information on clinical trials, new study finds

November 12, 2015
Despite legal and ethical requirements, information on clinical trials for drugs approved by the U.S. Food and Drug Administration (FDA) varied widely among some of the world's largest drug companies, according to a new study ...

Discontinuation of randomized clinical trials common

March 11, 2014
Approximately 25 percent of about 1,000 randomized clinical trials initiated between 2000 and 2003 were discontinued, with the most common reason cited being poor recruitment of volunteers; and less than half of these trials ...

New WHO statement on public reporting of clinical trial results announced

April 14, 2015
The World Health Organization (WHO) have announced a new statement on the public disclosure of clinical trial results which updates and expands a previous statement that noted the "the registration of all interventional trials ...

Calls for greater transparency in the release of clinical trial data

September 20, 2016
Researchers have called for greater transparency in the public release of clinical trial data after a study revealed significant under-reporting of side effects in medical treatments.

Industry-academia publication agreements include limits on publication of trial results

June 28, 2016
Publication agreements constraining academic investigators' independence are common, and incompletely reported in publications, according to a study published in this week's PLOS Medicine. The study, conducted by Matthias ...

Research Ethics Committees identify and correct problems in applications to do cancer trials

August 28, 2008
Researchers running cancer trials are often critical of the Research Ethics Committee (REC) process they have to go through to get their trials approved, complaining that it's too complex, burdensome and sometimes unreasonable. ...

Recommended for you

Tongue-in-cheek Nobels honor nutritional analysis of cannibalism, roller-coaster kidney stones treatment

September 14, 2018
A nutritional analysis of cannibalism and treating kidney stones on roller-coasters were research projects honored by tongue-in-cheek awards at Harvard University Thursday, designed to make you laugh first, and think later.

Pediatric robot patient offers new level of realism for doctors in training

September 10, 2018
A team of researchers and engineers at Gaumard Scientific has unveiled a new robot that raises the bar on medical training devices. The robot, called HAL, has been made to look like a five-year-old male patient and offers ...

Why men say they've had more lifetime sexual partners than women

July 25, 2018
The disparity between the number of sexual partners reported by men and women can largely be explained by a tendency among men to report extreme numbers of partners, and to estimate rather than count their lifetime total, ...

Censors jump into action as China's latest vaccine scandal ignites

July 22, 2018
Chinese censors on Sunday deleted articles and postings about the vaccine industry as an online outcry over the country's latest vaccine scandal intensified.

Revenge of a forgotten medical 'genius'

June 30, 2018
It's not an uncommon fate for a pioneering scientist: languishing unrecognised in his time before dying in obscurity. But as his 200th birthday approaches, the life-saving work of a Hungarian obstetrician is finally getting ...

Yes, you can put too much chlorine in a pool

June 2, 2018
(HealthDay)—Before you take a dip in the pool this summer, be sure there's not too much chlorine in the water.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.